Chen-Yuan Emily Lu, MD
Internal Medicine · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 3
- Since medical school
- 12 years
- Graduated 2014
Offices
3 locations · Sah Telemedicine - California PC · Pacific Inpatient Medical Group · Sah Telemedicine PC
Looking this up.
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A141244 · Current
Licensed to practise in California · since 2016 · expires 2027-07-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$2,819
Medicare paid this office $2,819 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 74 · Health risk score 1.55. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 74%.
The office billed $14,324, Medicare allowed $3,538 and paid $2,819; for 26 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 375 Part D prescriptions in 2022.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 375 | 134 | 0% (0) | None | $51,431 |
| 2021 | 3,558 | 317 | 2% (85) | 14% | $383,791 |
| 2020 | 3,565 | 304 | 4% (137) | 15% | $326,151 |
| 2019 | 2,988 | 316 | 3% (103) | 13% | $304,176 |
| 2018 | 2,128 | 271 | 5% (101) | 16% | $203,623 |
| 2017 | 422 | 96 | None | None | $27,124 |
| 2016 | 124 | 32 | None | 10% | $12,645 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 7 drugs
| Gabapentin | 19 | $1,048 | $55 |
| Atorvastatin | 42 | $624 | $15 |
| Metformin | 20 | $175 | $9 |
| Fluticasone Propionate | 12 | $146 | $12 |
| Simvastatin | 18 | $124 | $7 |
| Lisinopril | 12 | $103 | $9 |
| Amlodipine Besylate | 13 | $52 | $4 |
2021: 78 drugs
| Eliquis | 38 | $47,420 | $1,248 |
| Humulin 70/30 Kwikpen | 35 | $36,364 | $1,039 |
| Xarelto | 30 | $32,517 | $1,084 |
| Jardiance | 21 | $21,949 | $1,045 |
| Lantus Solostar | 24 | $14,761 | $615 |
| Trelegy Ellipta | 20 | $12,669 | $633 |
| Anoro Ellipta | 19 | $11,513 | $606 |
| Atorvastatin | 306 | $4,366 | $14 |
| Breo Ellipta | 11 | $4,042 | $367 |
| Buprenorphine-Naloxone | 15 | $3,818 | $255 |
| Bumetanide | 26 | $3,449 | $133 |
| Gabapentin | 104 | $3,408 | $33 |
| Venlafaxine Hcl Er | 23 | $2,893 | $126 |
| Humulin N | 15 | $2,369 | $158 |
| Pregabalin | 18 | $2,326 | $129 |
| Levothyroxine | 82 | $2,171 | $26 |
| Albuterol Sulfate Hfa | 65 | $2,038 | $31 |
| Oxybutynin Chloride Er | 33 | $1,736 | $53 |
| Losartan | 112 | $1,577 | $14 |
| Duloxetine | 55 | $1,411 | $26 |
| Ultra-Fine Short Pen Needle | 17 | $1,212 | $71 |
| Fluticasone Propionate | 71 | $1,080 | $15 |
| Metoprolol | 47 | $1,047 | $22 |
| Metformin | 125 | $1,039 | $8 |
| Hydrocodone-Acetaminophen | 44 | $958 | $22 |
| Valsartan | 19 | $930 | $49 |
| Glipizide Er | 34 | $823 | $24 |
| Diltiazem 24hr Er | 13 | $804 | $62 |
| Carvedilol | 78 | $802 | $10 |
| Mirtazapine | 47 | $801 | $17 |
| Hydralazine | 34 | $785 | $23 |
| Ventolin Hfa | 12 | $652 | $54 |
| Diclofenac | 21 | $642 | $31 |
| Tamsulosin | 56 | $638 | $11 |
| Spironolactone | 26 | $595 | $23 |
| Metformin Hcl Er | 76 | $594 | $8 |
| Amlodipine Besylate | 142 | $570 | $4 |
| Nystatin | 14 | $552 | $39 |
| Rosuvastatin | 29 | $534 | $18 |
| Baclofen | 15 | $529 | $35 |
| Simvastatin | 74 | $482 | $7 |
| Lisinopril | 86 | $459 | $5 |
| Famotidine | 32 | $457 | $14 |
| Lisinopril-Hydrochlorothiazide | 65 | $451 | $7 |
| Valsartan-Hydrochlorothiazide | 11 | $436 | $40 |
| Pravastatin | 27 | $416 | $15 |
| Pioglitazone | 27 | $377 | $14 |
| Clopidogrel | 33 | $367 | $11 |
| Pantoprazole | 46 | $367 | $8 |
| Benazepril | 35 | $358 | $10 |
| Montelukast | 41 | $328 | $8 |
| Trazodone | 28 | $316 | $11 |
| Nortriptyline | 16 | $313 | $20 |
| Losartan-Hydrochlorothiazide | 12 | $300 | $25 |
| Lovastatin | 27 | $272 | $10 |
| Metoprolol | 34 | $270 | $8 |
| Furosemide | 44 | $254 | $6 |
| Allopurinol | 16 | $254 | $16 |
| Warfarin | 15 | $228 | $15 |
| Glipizide | 17 | $214 | $13 |
| Donepezil | 26 | $213 | $8 |
| Nitroglycerin | 19 | $212 | $11 |
| Metoclopramide | 15 | $198 | $13 |
| Finasteride | 15 | $189 | $13 |
| Oxybutynin Chloride | 15 | $177 | $12 |
| Sertraline | 18 | $177 | $10 |
| Omeprazole | 29 | $173 | $6 |
| Tramadol | 12 | $146 | $12 |
| Alendronate | 15 | $142 | $9 |
| Hydrochlorothiazide | 22 | $137 | $6 |
| Prednisone | 37 | $135 | $4 |
| Oxycodone | 12 | $128 | $11 |
| Azithromycin | 15 | $128 | $9 |
| Acyclovir | 15 | $126 | $8 |
| Meclizine | 11 | $117 | $11 |
| Ibuprofen | 12 | $112 | $9 |
| Triamcinolone Acetonide | 16 | $101 | $6 |
| Citalopram Hbr | 14 | $100 | $7 |
2020: 83 drugs
| Eliquis | 44 | $36,309 | $825 |
| Xarelto | 30 | $25,040 | $835 |
| Humulin 70/30 Kwikpen | 22 | $18,645 | $847 |
| Humulin 70-30 | 20 | $11,058 | $553 |
| Buprenorphine-Naloxone | 33 | $8,527 | $258 |
| Lantus Solostar | 11 | $7,827 | $712 |
| Insulin Lispro Kwikpen U-100 | 11 | $6,731 | $612 |
| Linzess | 11 | $5,714 | $519 |
| Humulin N | 18 | $5,293 | $294 |
| Atorvastatin | 250 | $4,992 | $20 |
| Lidocaine | 14 | $4,593 | $328 |
| Breo Ellipta | 12 | $4,326 | $360 |
| Bumetanide | 28 | $4,167 | $149 |
| Venlafaxine Hcl Er | 33 | $3,881 | $118 |
| Qvar Redihaler | 13 | $3,754 | $289 |
| Solifenacin | 11 | $3,385 | $308 |
| Albuterol Sulfate Hfa | 79 | $3,138 | $40 |
| Gabapentin | 144 | $3,053 | $21 |
| Levothyroxine | 100 | $2,074 | $21 |
| Hydrocodone-Acetaminophen | 61 | $1,814 | $30 |
| Isosorbide Dinitrate | 12 | $1,494 | $124 |
| Baclofen | 29 | $1,378 | $48 |
| Oxybutynin Chloride Er | 26 | $1,294 | $50 |
| Duloxetine | 64 | $1,154 | $18 |
| Metoprolol | 59 | $1,075 | $18 |
| Morphine Sulfate Er | 11 | $1,028 | $93 |
| Diclofenac | 29 | $968 | $33 |
| Mirtazapine | 38 | $913 | $24 |
| Ventolin Hfa | 16 | $886 | $55 |
| Trazodone | 53 | $871 | $16 |
| Losartan | 94 | $869 | $9 |
| Fluticasone Propionate | 39 | $867 | $22 |
| Hydralazine | 43 | $855 | $20 |
| Rosuvastatin | 24 | $807 | $34 |
| Metformin | 121 | $776 | $6 |
| Doxycycline Hyclate | 14 | $760 | $54 |
| Insulin | 13 | $750 | $58 |
| Valsartan | 22 | $569 | $26 |
| Spironolactone | 18 | $558 | $31 |
| Famotidine | 40 | $544 | $14 |
| Tamsulosin | 65 | $533 | $8 |
| Lisinopril | 77 | $522 | $7 |
| Amlodipine Besylate | 111 | $496 | $4 |
| Pravastatin | 30 | $494 | $16 |
| Glipizide Er | 24 | $494 | $21 |
| Montelukast | 25 | $458 | $18 |
| Carvedilol | 47 | $398 | $8 |
| Valacyclovir | 13 | $390 | $30 |
| Furosemide | 66 | $379 | $6 |
| Metformin Hcl Er | 56 | $378 | $7 |
| Oxycodone | 28 | $359 | $13 |
| Propranolol | 19 | $357 | $19 |
| Pioglitazone | 19 | $351 | $18 |
| Simvastatin | 63 | $347 | $6 |
| Omeprazole | 31 | $327 | $11 |
| Sulindac | 12 | $326 | $27 |
| Prednisone | 58 | $297 | $5 |
| Metoclopramide | 24 | $285 | $12 |
| Clopidogrel | 22 | $284 | $13 |
| Lisinopril-Hydrochlorothiazide | 40 | $277 | $7 |
| Lovastatin | 24 | $276 | $12 |
| Pantoprazole | 35 | $246 | $7 |
| Metoprolol | 40 | $246 | $6 |
| Tramadol | 28 | $244 | $9 |
| Oxybutynin Chloride | 21 | $239 | $11 |
| Azithromycin | 15 | $236 | $16 |
| Ropinirole | 11 | $232 | $21 |
| Benazepril | 19 | $226 | $12 |
| Warfarin | 12 | $217 | $18 |
| Valsartan-Hydrochlorothiazide | 16 | $213 | $13 |
| Sertraline | 16 | $205 | $13 |
| Allopurinol | 14 | $203 | $14 |
| Ibuprofen | 25 | $186 | $7 |
| Hydrochlorothiazide | 21 | $170 | $8 |
| Alendronate | 15 | $113 | $8 |
| Lamotrigine | 17 | $110 | $6 |
| Donepezil | 26 | $106 | $4 |
| Citalopram Hbr | 20 | $106 | $5 |
| Nortriptyline | 13 | $104 | $8 |
| Glipizide | 18 | $101 | $6 |
| Finasteride | 13 | $100 | $8 |
| Lorazepam | 14 | $94 | $7 |
| Fluoxetine | 15 | $60 | $4 |
2019: 68 drugs
| Humulin 70/30 Kwikpen | 15 | $16,702 | $1,113 |
| Xarelto | 23 | $15,867 | $690 |
| Buprenorphine-Naloxone | 35 | $15,745 | $450 |
| Eliquis | 18 | $14,980 | $832 |
| Humulin 70-30 | 23 | $12,858 | $559 |
| Duloxetine | 50 | $11,392 | $228 |
| Atorvastatin | 203 | $6,370 | $31 |
| Gabapentin | 92 | $5,280 | $57 |
| Humulin N | 14 | $5,043 | $360 |
| Lidocaine | 18 | $5,021 | $279 |
| Rosuvastatin | 27 | $4,201 | $156 |
| Qvar Redihaler | 11 | $3,195 | $290 |
| Tamsulosin | 49 | $2,677 | $55 |
| Bumetanide | 26 | $2,633 | $101 |
| Venlafaxine Hcl Er | 13 | $2,514 | $193 |
| Divalproex Sodium Er | 14 | $2,388 | $171 |
| Metoprolol | 56 | $2,275 | $41 |
| Levothyroxine | 81 | $2,258 | $28 |
| Oxybutynin Chloride Er | 22 | $2,180 | $99 |
| Hydrocodone-Acetaminophen | 59 | $2,002 | $34 |
| Amlodipine Besylate | 105 | $1,936 | $18 |
| Simvastatin | 64 | $1,365 | $21 |
| Ventolin Hfa | 23 | $1,327 | $58 |
| Warfarin | 51 | $1,327 | $26 |
| Doxycycline Hyclate | 23 | $1,290 | $56 |
| Losartan | 79 | $1,276 | $16 |
| Isosorbide Dinitrate | 15 | $1,262 | $84 |
| Cartia Xt | 18 | $1,184 | $66 |
| Montelukast | 21 | $1,073 | $51 |
| Clopidogrel | 34 | $1,004 | $30 |
| Diclofenac | 20 | $945 | $47 |
| Metformin | 82 | $915 | $11 |
| Omeprazole | 21 | $870 | $41 |
| Fluticasone Propionate | 13 | $837 | $64 |
| Carvedilol | 35 | $812 | $23 |
| Lisinopril-Hydrochlorothiazide | 37 | $804 | $22 |
| Oxybutynin Chloride | 18 | $793 | $44 |
| Baclofen | 19 | $690 | $36 |
| Trazodone | 41 | $672 | $16 |
| Donepezil | 20 | $661 | $33 |
| Lisinopril | 64 | $639 | $10 |
| Allopurinol | 18 | $639 | $35 |
| Glipizide | 34 | $634 | $19 |
| Metformin Hcl Er | 42 | $589 | $14 |
| Metoprolol | 40 | $580 | $14 |
| Insulin | 12 | $556 | $46 |
| Sertraline | 26 | $504 | $19 |
| Spironolactone | 23 | $491 | $21 |
| Hydralazine | 19 | $483 | $25 |
| Famotidine | 57 | $475 | $8 |
| Furosemide | 49 | $457 | $9 |
| Finasteride | 14 | $398 | $28 |
| Citalopram Hbr | 21 | $397 | $19 |
| Glipizide Er | 12 | $395 | $33 |
| Tramadol | 14 | $392 | $28 |
| Pravastatin | 18 | $370 | $21 |
| Metoclopramide | 24 | $360 | $15 |
| Pantoprazole | 26 | $346 | $13 |
| Propranolol | 12 | $328 | $27 |
| Amoxicillin-Clavulanate Potass | 12 | $259 | $22 |
| Oxycodone | 20 | $238 | $12 |
| Prednisone | 59 | $192 | $3 |
| Triamcinolone Acetonide | 18 | $163 | $9 |
| Alendronate | 15 | $158 | $11 |
| Lorazepam | 14 | $150 | $11 |
| Benazepril | 12 | $148 | $12 |
| Naproxen | 12 | $133 | $11 |
| Hydrochlorothiazide | 16 | $118 | $7 |
2018: 52 drugs
| Eliquis | 24 | $13,925 | $580 |
| Humulin 70-30 | 27 | $13,304 | $493 |
| Gabapentin | 77 | $6,727 | $87 |
| Humulin N | 14 | $6,382 | $456 |
| Lidocaine | 13 | $6,033 | $464 |
| Atorvastatin | 130 | $5,067 | $39 |
| Duloxetine | 17 | $4,663 | $274 |
| Bumetanide | 29 | $2,843 | $98 |
| Diclofenac | 42 | $2,766 | $66 |
| Divalproex Sodium Er | 12 | $2,656 | $221 |
| Metoprolol | 41 | $2,612 | $64 |
| Rosuvastatin | 14 | $2,381 | $170 |
| Tamsulosin | 36 | $1,810 | $50 |
| Amlodipine Besylate | 58 | $1,476 | $25 |
| Levothyroxine | 43 | $1,472 | $34 |
| Trazodone | 49 | $1,348 | $28 |
| Lisinopril | 63 | $1,159 | $18 |
| Hydrocodone-Acetaminophen | 43 | $1,151 | $27 |
| Omeprazole | 20 | $1,134 | $57 |
| Proair Hfa | 14 | $1,039 | $74 |
| Montelukast | 18 | $952 | $53 |
| Clopidogrel | 23 | $941 | $41 |
| Spironolactone | 22 | $883 | $40 |
| Oxycodone | 33 | $880 | $27 |
| Losartan | 47 | $742 | $16 |
| Sertraline | 18 | $690 | $38 |
| Citalopram Hbr | 24 | $689 | $29 |
| Furosemide | 53 | $646 | $12 |
| Insulin | 14 | $602 | $43 |
| Nystatin | 13 | $599 | $46 |
| Warfarin | 33 | $573 | $17 |
| Fluticasone Propionate | 15 | $572 | $38 |
| Simvastatin | 26 | $567 | $22 |
| Cartia Xt | 14 | $547 | $39 |
| Pravastatin | 18 | $545 | $30 |
| Pantoprazole | 23 | $489 | $21 |
| Famotidine | 50 | $465 | $9 |
| Carvedilol | 23 | $458 | $20 |
| Doxycycline Hyclate | 14 | $431 | $31 |
| Metformin | 29 | $401 | $14 |
| Lorazepam | 18 | $360 | $20 |
| Nitrofurantoin Mono-Macro | 13 | $342 | $26 |
| Triamcinolone Acetonide | 11 | $338 | $31 |
| Paroxetine | 11 | $299 | $27 |
| Metoprolol | 21 | $292 | $14 |
| Risperidone | 15 | $284 | $19 |
| Metformin Hcl Er | 17 | $241 | $14 |
| Ciprofloxacin | 17 | $230 | $14 |
| Naproxen | 11 | $188 | $17 |
| Prednisone | 35 | $162 | $5 |
| Glipizide | 15 | $145 | $10 |
| Metoclopramide | 11 | $129 | $12 |
2017: 9 drugs
| Atorvastatin | 30 | $603 | $20 |
| Tamsulosin | 19 | $377 | $20 |
| Amlodipine Besylate | 22 | $166 | $8 |
| Losartan-Hydrochlorothiazide | 17 | $163 | $10 |
| Metformin | 12 | $127 | $11 |
| Triamcinolone Acetonide | 12 | $122 | $10 |
| Fluticasone Propionate | 11 | $119 | $11 |
| Furosemide | 12 | $98 | $8 |
| Famotidine | 16 | $95 | $6 |
2016: 1 drug
| Atorvastatin | 15 | $312 | $21 |
Money from drug and device companies
$35 in 2024
| 2024 | 1 | 1 | None | $35 |
| 2023 | 1 | 2 | None | $410 |
| 2022 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Aptima | $35 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2024-01-17 | Aptima | $35 |
See earlier years (2023, 2022)
2023: $410
| Medtronic | Micra | $410 | 2 payments
|
2022: $24
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
Professional record
- NPI
- 1174934566
- Licence
- CA A141244California A141244: Current · expires 2027-07-31
- Group
- Sah Telemedicine - California PC · Pacific Inpatient Medical Group · Sah Telemedicine PC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1500 Mission St, San Francisco, CA, 94103
- NPI first listed
- 2014-05-19
- NPI last updated
- 2025-03-03
- NPI record certified
- 2025-03-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1743 S Sidewinder Drive Unit 114, Park City, UT, 84060